These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4299476)

  • 1. [Derivatives of viomycin. II. Preparation and properties of some viomycin penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1968; 25(4):407-10. PubMed ID: 4299476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Derivatives of viomycin. I. Preparation and properties of viomycin nicotinate and isonicotinate].
    Sobiczewski W; Cieślak J; Waszkiewicz A; Chojnowski W
    Acta Pol Pharm; 1968; 25(4):403-5. PubMed ID: 4299475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Viomycin derivatives. IV. Preparation and properties of some penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1969; 26(1):29-32. PubMed ID: 4305691
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of some viomycinmethyltetracyclines].
    Sobiczewski W; Cendrowska H; Chojnowski W
    Acta Pol Pharm; 1969; 26(6):505-10. PubMed ID: 4314647
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDIES ON THE ANTIBACTERIAL SPECTRUM AND DETERMINATION OF THE BIOLOGICAL ACTIVITY OF FLORIMYCIN (VIOMYCIN)].
    TEBIAKINA AE; BUIANOVSKAIA IS; CHAIKOVSKAIA SM; SHNEERSON AN
    Antibiotiki; 1963 Oct; 8():901-5. PubMed ID: 14136417
    [No Abstract]   [Full Text] [Related]  

  • 6. [Derivatives of viomycin. V. Di(oxytetracyclinemethyl)viomycin and tri(oxytetracyclinemethyl)viomycin, preparation and properties].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1969; 26(3):237-40. PubMed ID: 4308291
    [No Abstract]   [Full Text] [Related]  

  • 7. [Derivatives of viomycin. 3. Viomycin-methyltetracyclines, their preparation and properties].
    Sobiczewski W; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1968; 25(6):563-7. PubMed ID: 4307876
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of taxonomic characteristics of highly active viomycin-producing mutants of Streptomyces griseus var. purpureus.
    Tyc M; Kadzikiewicz T
    Acta Microbiol Pol B; 1972; 4(4):217-26. PubMed ID: 4345459
    [No Abstract]   [Full Text] [Related]  

  • 10. Catalytic hydrogenation of viomycin and capreomycin.
    Dyer JR; Carter JH; van Wyk PJ
    J Med Chem; 1971 Nov; 14(11):1120-1. PubMed ID: 4329900
    [No Abstract]   [Full Text] [Related]  

  • 11. [Semisynthetic penicillins with a chemical group with their own pharmacological activity].
    Alhaique F; Giacomello G; Riccieri FM; Santucci E
    Farmaco Sci; 1968 Nov; 23(11):1097-103. PubMed ID: 4976632
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on viomycin. VII. Oxidative modifications of viomycin.
    Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 14. VIOMYCIN: II. THE STRUCTURE OF VIOMYCIN.
    DYER JR; KELLOGG CK; NASSAR RF; STREETMAN WE
    Tetrahedron Lett; 1965 Mar; 10():585-92. PubMed ID: 14295189
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of the antimicrobial properties of phytoncides of some edible plants of the Carpathian region].
    Furchuk RP
    Vopr Pitan; 1966; 25(6):68-71. PubMed ID: 4972495
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of protein synthesis by fusidic and helvolinic acids, steroidal antibiotics.
    Yamaki H
    J Antibiot (Tokyo); 1965 Sep; 18(5):228-32. PubMed ID: 4955236
    [No Abstract]   [Full Text] [Related]  

  • 17. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J; Bönicke R
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract]   [Full Text] [Related]  

  • 18. [ISOLATION, CHEMICAL PURIFICATION AND PROPERTIES OF FLORIMYCIN (VIOMYCIN)].
    MAMIOFE SM; OPARYSHEVA EF; GREBENIK MD; NAGORNAIA TN; PREOBRAZHENSKAIA EV
    Antibiotiki; 1963 Oct; 8():895-900. PubMed ID: 14136416
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium.
    Engbaek HC; Vergmann B; Baess I
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(5):619-31. PubMed ID: 4322001
    [No Abstract]   [Full Text] [Related]  

  • 20. Arginine in viomycin biosynthesis.
    Paśś L; Raczyńska-Bojanowska K
    Acta Biochim Pol; 1969; 16(3):297-311. PubMed ID: 4312843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.